KEGG   Equus caballus (horse): 100054988
Entry
100054988         CDS       T01058                                 
Symbol
BID
Name
(RefSeq) BH3-interacting domain death agonist
  KO
K04726  BH3 interacting domain death agonist
Organism
ecb  Equus caballus (horse)
Pathway
ecb01524  Platinum drug resistance
ecb04071  Sphingolipid signaling pathway
ecb04115  p53 signaling pathway
ecb04210  Apoptosis
ecb04215  Apoptosis - multiple species
ecb04217  Necroptosis
ecb04650  Natural killer cell mediated cytotoxicity
ecb04932  Non-alcoholic fatty liver disease
ecb05010  Alzheimer disease
ecb05014  Amyotrophic lateral sclerosis
ecb05022  Pathways of neurodegeneration - multiple diseases
ecb05152  Tuberculosis
ecb05160  Hepatitis C
ecb05161  Hepatitis B
ecb05162  Measles
ecb05163  Human cytomegalovirus infection
ecb05164  Influenza A
ecb05167  Kaposi sarcoma-associated herpesvirus infection
ecb05168  Herpes simplex virus 1 infection
ecb05169  Epstein-Barr virus infection
ecb05170  Human immunodeficiency virus 1 infection
ecb05200  Pathways in cancer
ecb05416  Viral myocarditis
ecb05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:ecb00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    100054988 (BID)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    100054988 (BID)
   04215 Apoptosis - multiple species
    100054988 (BID)
   04217 Necroptosis
    100054988 (BID)
   04115 p53 signaling pathway
    100054988 (BID)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    100054988 (BID)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    100054988 (BID)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    100054988 (BID)
   05161 Hepatitis B
    100054988 (BID)
   05160 Hepatitis C
    100054988 (BID)
   05164 Influenza A
    100054988 (BID)
   05162 Measles
    100054988 (BID)
   05168 Herpes simplex virus 1 infection
    100054988 (BID)
   05163 Human cytomegalovirus infection
    100054988 (BID)
   05167 Kaposi sarcoma-associated herpesvirus infection
    100054988 (BID)
   05169 Epstein-Barr virus infection
    100054988 (BID)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    100054988 (BID)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    100054988 (BID)
   05014 Amyotrophic lateral sclerosis
    100054988 (BID)
   05022 Pathways of neurodegeneration - multiple diseases
    100054988 (BID)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    100054988 (BID)
   05416 Viral myocarditis
    100054988 (BID)
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    100054988 (BID)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    100054988 (BID)
SSDB
Motif
Pfam: BID Bcl-2 bcl-2I13
Other DBs
NCBI-GeneID: 100054988
NCBI-ProteinID: XP_005610875
Ensembl: ENSECAG00000006592
VGNC: 15829
LinkDB
Position
6:28481595..28509113
AA seq 194 aa
MDSKVSNGSGLQDEHITHLLVFSFLQNCSKRHFYKELEVLGHELPVQAYLWEDHDELQTD
GNRCSHFVARAEADSESQEEIIQHIARQLAQIGDRMDDSIHPRLVNNLAMQFMNVNLSEE
DRRQCLTSALEQVMQTYPKDMEKEKTMLMLSMLLAKKVANHTPSLLRDVFRTTVNFINQN
LLTYVRNLVRNEMD
NT seq 585 nt   +upstreamnt  +downstreamnt
atggattctaaggtcagcaatggttcaggcctccaggatgagcacatcacacacttgctg
gtgtttagcttcctccaaaactgctccaaacgtcatttctacaaagagctggaggtgttg
ggccatgaactgcccgtgcaagcttacctgtgggaggaccatgacgagctgcagacagat
ggcaaccggtgcagccacttcgtggcaagagcggaggcagattctgagagtcaagaggaa
ataatccagcatatcgccaggcaacttgcccaaataggggacaggatggacgacagcatc
cacccaaggctggtgaataacctggcaatgcagtttatgaatgtgaacctgtcggaggaa
gacagaagacagtgccttacttctgcgctggagcaggtcatgcagacttatcctaaagac
atggagaaggagaagaccatgctgatgttgtccatgctcttggccaaaaaggtggccaat
cacacaccgtctttgctccgtgacgtctttcgcacaacagtgaactttattaaccagaac
ctactcacctatgtgaggaacttagtcagaaatgagatggattga

DBGET integrated database retrieval system